Drug Profile
Research programme: platelet ADP receptor inhibitors - Millennium
Alternative Names: Platelet ADP receptor inhibitors research programme - MillenniumLatest Information Update: 14 Jun 2005
Price :
$50
*
At a glance
- Originator Millennium Pharmaceuticals
- Class
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders; Reperfusion injury; Stroke
Most Recent Events
- 14 Jun 2005 No development reported - Preclinical for Ischaemic heart disorders in USA (unspecified route)
- 14 Jun 2005 No development reported - Preclinical for Reperfusion injury in USA (unspecified route)
- 14 Jun 2005 No development reported - Preclinical for Stroke in USA (unspecified route)